Mesa Laboratories Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	245.26	240.98	216.19	219.08	184.34	133.94
Revenue Growth (YoY)	7.39%	11.47%	-1.32%	18.85%	37.63%	13.81%
Cost of Revenue	92.82	88.88	81.71	85.39	75.25	46.92
Gross Profit	152.44	152.1	134.48	133.69	109.09	87.01
Selling, General & Admin	117.22	115.02	111.49	109.88	88.62	64.27
Research & Development	20.18	19.52	19.3	20.49	15.77	10.39
Operating Expenses	137.4	134.53	130.79	130.37	104.39	74.66
Operating Income	15.04	17.57	3.69	3.32	4.7	12.36
Interest Expense	-11.06	-11.86	-5.7	-4.77	-3.89	-8.02
Other Non Operating Income (Expenses)	3.28	-1.4	2.12	1.06	2.76	-2.03
EBT Excluding Unusual Items	7.26	4.31	0.11	-0.39	3.57	2.3
Merger & Restructuring Charges	-	-1.23	-1.23	-	-	-
Impairment of Goodwill	-	-	-156.89	-	-	-
Asset Writedown	-	-	-117.64	-	-	-
Other Unusual Items	-	2.89	-	-	-	-
Pretax Income	7.26	5.96	-275.65	-0.39	3.57	2.3
Income Tax Expense	8.83	7.94	-21.4	-1.32	1.7	-0.97
Net Income	-1.57	-1.97	-254.25	0.93	1.87	3.27
Net Income to Common	-1.57	-1.97	-254.25	0.93	1.87	3.27
Net Income Growth	-	-	-	-50.29%	-42.85%	84.14%
Shares Outstanding (Basic)	5	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5	5
Shares Change (YoY)	1.18%	0.65%	0.47%	0.49%	4.12%	17.23%
EPS (Basic)	-0.29	-0.36	-47.20	0.17	0.36	0.66
EPS (Diluted)	-0.29	-0.36	-47.20	0.17	0.35	0.64
EPS Growth	-	-	-	-51.43%	-45.31%	56.10%
Free Cash Flow	37.24	42.56	41.57	23.44	34.79	35.08
Free Cash Flow Per Share	6.82	7.85	7.72	4.37	6.52	6.85
Dividend Per Share	0.640	0.640	0.640	0.640	0.640	0.640
Gross Margin	62.15%	63.12%	62.20%	61.02%	59.18%	64.97%
Operating Margin	6.13%	7.29%	1.70%	1.52%	2.55%	9.23%
Profit Margin	-0.64%	-0.82%	-117.61%	0.43%	1.01%	2.44%
Free Cash Flow Margin	15.18%	17.66%	19.23%	10.70%	18.87%	26.19%
EBITDA	39.84	42.1	35.26	36.45	29.77	30.02
EBITDA Margin	16.24%	17.47%	16.31%	16.64%	16.15%	22.41%
D&A For EBITDA	24.8	24.53	31.57	33.13	25.07	17.66
EBIT	15.04	17.57	3.69	3.32	4.7	12.36
EBIT Margin	6.13%	7.29%	1.70%	1.52%	2.55%	9.23%
Effective Tax Rate	121.67%	133.12%	-	-	47.65%	-
Revenue as Reported	240.98	240.98	216.19	219.08	184.34	133.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.